Hybrid risk adjustment for pharmaceutical benefits

European Journal of Health Economics

Volumn 10, Issue 3, 2009, Pages 299-308

  García Goñi, Manuel ^a   Ibern, Pere ^b   Inoriza, José María ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DEPARTMENT OF ECONOMICS AND BUSINESS   (Spain)

^c University Hospital   (Spain)

Author keywords

Clinical risk groups; Drug expenditure; Hybrid risk adjustment; Morbidity

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MODEL; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; SPAIN;

ADULT; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEALTH STATUS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; NATIONAL HEALTH PROGRAMS; RISK ADJUSTMENT; RISK ASSESSMENT; SPAIN;

EID: 67649224155     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0133-2     Document Type: Article

References (37)

1. SH Zuvekas JW Cohen 2007 Prescription drugs and the changing concentration of health care expenditures Health Aff. 26 1 249 257
2. ML Berk AC Monheit 2001 The concentration of health care expenditures, revisited Health Aff 20 2 9 18 (Pubitemid 33710272)
3. SG Morgan 2006 Prescription drug expenditures and population demographics Health Serv. Res 41 2 411 428 (Pubitemid 43374279)
4. Ibern, P., Inoriza, J.M.: La despesa farmaceutica segons morbiditat. Cap.5 en Estudis d'Economia de la Salut, pp 111-138. Generalitat de Catalunya, Departement de Salut, Barcelona. http://www.gencat.net/salut/depsan/units/ sanitat/pdf/estudissalut2007.pdf (2006)
5. N Rice P Dixon DC Lloyd D Roberts 2000 Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis BMJ 320 284 288
6. A García-Sempere S Peiró 2001 Gasto farmacéutico en atención primaria: variables asociadas y asignación de presupuestos de farmacia por zonas de salud Gac. Sanit. 15 32 40
7. AT Healey BF Yule JP Reid 1994 Variation in general practice prescribing costs and implications for budget setting Health Econ 3 1 1 47
8. MV Wrobel J Doshi BC Stuart B Briesacher 2003 Predictability of prescription drug expenditures for Medicare beneficiaries Health Care Financ. Rev 25 2 37 46 (Pubitemid 38500730)
9. García-Goñi, M.: El Ajuste de Riesgos en los mercados sanitarios; Experiencias Europeas. In: Ibern, P. (ed.) Integración asistencial: fundamentos, experiencias y vías de avance, pp. 187-208. Masson, Barcelona (2006)
10. Thomas, J.W.: Should episode-based economic profiles be risk adjusted to account for differences in patients' health risks? Health Serv. Res. 41(2):581-598 (2006). doi: 10.1111/j.1475-6773.2005.00499.x
11. KM Antioch RP Ellis S Gillett D Borovnicar RP Marshall 2007 Risk adjustment policy options for casemix funding: international lessons in financing reform Eur. J. Health Econ 8 195 212 (Pubitemid 47231307)
12. Van de Ven, W.P.M.M., Ellis, R.P.: Risk adjustment in competitive health plan markets. In: Culyer, A.J., Newhouse, J.P. (eds.) Handbook of health economics. Elsevier, Amsterdam (2000)
13. E Schokkaert C Van de Voorde 2003 Belgium: risk adjustment and financial responsibility in a centralised system Health Policy 65 5 19 (Pubitemid 36765341)
14. LM Lamers RCJA Van Vliet WPMM Van de Ven 2003 Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands Health Policy 65 49 62 (Pubitemid 36765344)
15. C Behrend F Buchner M Happich R Holle P Reitmeir J Wasem 2007 Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set Eur. J. Health Econ 8 31 39 (Pubitemid 46295337)
16. F Buchner J Wasem 2003 Needs for further improvement: risk adjustment in the German Health Insurance System Health Policy 65 21 35 (Pubitemid 36765342)
17. K Beck S Spycher A Holly L Gardiol 2003 Risk adjustment in Switzerland Health Policy 65 63 74 (Pubitemid 36765345)
18. A Shmueli D Chernichovsky I Zmora 2003 Risk adjustment and risk sharing: the Israeli experience Health Policy 65 37 48 (Pubitemid 36765343)
19. WPMM Van de Ven RCJA Van Vliet E Schut EM Van Barneveld 2000 Access coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjustment premium subsidies? J Health Econ 19 311 339 (Pubitemid 30195790)
20. M García-Goñi P Ibern 2008 Predictability of drug expenditures: an application using morbidity data Health Econ 17 1 119 126 (Pubitemid 351227531)
21. JP Newhouse 1996 Reimbursing health plans and health providers: efficiency in production versus selection J. Econ. Lit 34 1236 1263 (Pubitemid 126420568)
22. EM Van Barneveld LM Lamers RCJA Van Vliet WPMM Van de Ven 2001 Risk sharing as a supplement to imperfect capitation in health insurance: a tradeoff between selection and efficiency J. Health Econ 20 147 168 (Pubitemid 32143701)
23. Van Barneveld, E.M.: Risk sharing as a supplement to imperfect capitation in health insurance: a tradeoff between selection and efficiency. Doctoral dissertation, Erasmus University, Rotterdam (2000)
24. EM Van Barneveld LM Lamers RCJA Van Vliet WPMM Van de Ven 1997 Mandatory pooling as a supplement to risk-adjustment capitation payments in a competitive health insurance market Soc. Sci. Med 47 223 232 (Pubitemid 28297259)
25. WPMM Van de Ven K Beck 2003 Risk adjustment and risk selection on the sickness fund insurance market in five European countries Health Policy 65 75 98 (Pubitemid 36765346)
26. JC Beebe 1992 An outlier pool for medicare HMO payments Health Care Financ. Rev 14 1 59 63 (Pubitemid 23088032)
27. RP Ellis TG McGuire 1988 Insurance principles and the design of prospective payment systems J. Health Econ 7 215 237 (Pubitemid 19017367)
28. EB Keeler T Carter 1988 Insurance aspects of DRG outlier payments J. Health Econ 7 193 214 (Pubitemid 19017366)
29. Y Zhao RP Ellis AS Ash D Calabrese JZ Ayanian JP Slaughter 2001 Measuring population health risks using inpatient diagnoses and outpatient pharmacy data Health Serv. Res. 36 180 193
30. Y Zhao AS Ash RP Ellis JZ Ayanian GC Pope B Bowen 2005 Predicting pharmacy costs and other medical costs using diagnoses and drug claims Med. Care 43 1 34 43 (Pubitemid 40137612)
31. RA Dudley CA Medlin LB Hammann MG Cisternas R Brand DJ Rennie 2003 The best of both worlds? The potential of hybrid prospective/concurrent risk adjustment Med. Care 41 1 56 69
32. HS Luft RA Dudley 2004 Assessing risk adjustment approaches under non-random selection Inquiry 41 203 217 (Pubitemid 39193288)
33. Winkelman, R., Mehmud, S.A.: A comparative analysis of claims-based tools for health risk assessment. Society of Actuaries sponsored Research Project. http://www.soa.org/soaweb/files/pdf/risk-assessmentc.pdf (2007). Accessed 21 July 2007
34. OECD: Health data (2007)
35. JS Hughes RF Averill J Eisenhandler NI Goldfield J Muldoon JM Neff 2004 Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management Med. Care 42 1 81 90
36. JM Inoriza J Coderch M Carreras L Vall-Llosera M García-Goñi JM Lisbona P Ibern 2008 La medida de la morbilidad atendida en una organización sanitaria integrada Gac. Sanit. 22 1 11
37. SL Ettner RG Frank TG McGuire RC Hermann 2001 Risk adjustment alternatives in paying for behavioral health care under Medicaid Health Serv. Res 36 793 811 (Pubitemid 32738733)